Literature DB >> 22817813

Factors associated with development of complications among adults with influenza: a 3-year prospective analysis.

Un-In Wu1, Jann-Tay Wang, Ya-Chi Ho, Sung-Ching Pan, Yee-Chun Chen, Shan-Chwen Chang.   

Abstract

BACKGROUND/
PURPOSE: This prospective study aimed to describe the clinical features, as well as outcomes, of adult patients with influenza of different severity, and to determine the predictors for development of complications.
METHODS: From December 2006 to March 2009, four types of diagnostic tests were given to both in- and outpatients with influenza-like illness (ILI). Confirmed cases were categorized into three groups (uncomplicated, moderately complicated, and severely complicated) for analysis using a proportional odds logistic regression model.
RESULTS: A total of 206 laboratory-confirmed cases of influenza were identified out of 360 enrolled patients with ILI. Among 30 patients (14.6%) classified as complicated cases due to development of pneumonia (n=28) and viral encephalopathy (n=2), 16 were hospitalized in general wards (moderately complicated) and 14 required admission to intensive care units (severely complicated). Complicated patients were less likely to have classic symptoms of ILI than uncomplicated patients. By multivariate analysis, the presence of coronary artery disease, systemic corticosteroid use, impaired renal function and delayed hospital visit were independently associated with development of complications.
CONCLUSION: Our study results may help clinicians to identify patients at high risk for complicated influenza, to provide timely antiviral therapy and optimal clinical care.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817813     DOI: 10.1016/j.jfma.2011.04.005

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  7 in total

1.  Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Zhikang Ye; Ying Wang; Luis Enrique Colunga-Lozano; Manya Prasad; Wimonchat Tangamornsuksan; Bram Rochwerg; Liang Yao; Shahrzad Motaghi; Rachel J Couban; Maryam Ghadimi; Malgorzata M Bala; Huda Gomaa; Fang Fang; Yingqi Xiao; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-05-14       Impact factor: 8.262

2. 

Authors:  Zhikang Ye; Ying Wang; Luis Enrique Colunga-Lozano; Manya Prasad; Wimonchat Tangamornsuksan; Bram Rochwerg; Liang Yao; Shahrzad Motaghi; Rachel J Couban; Maryam Ghadimi; Malgorzata M Bala; Huda Gomaa; Fang Fang; Yingqi Xiao; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

3.  Corticosteroids as adjunctive therapy in the treatment of influenza.

Authors:  Louise Lansbury; Chamira Rodrigo; Jo Leonardi-Bee; Jonathan Nguyen-Van-Tam; Wei Shen Lim
Journal:  Cochrane Database Syst Rev       Date:  2019-02-24

4.  Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study.

Authors:  Laurence Fardet; Irene Petersen; Irwin Nazareth
Journal:  PLoS Med       Date:  2016-05-24       Impact factor: 11.069

5.  Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis.

Authors:  Brenda L Coleman; Shaza A Fadel; Tiffany Fitzpatrick; Sera-Melisa Thomas
Journal:  Influenza Other Respir Viruses       Date:  2017-12-02       Impact factor: 4.380

Review 6.  Immunosuppressive agents for dermatological indications in the ongoing COVID-19 pandemic: Rationalizing use and clinical applicability.

Authors:  Ananta Khurana; Snigdha Saxena
Journal:  Dermatol Ther       Date:  2020-06-23       Impact factor: 3.858

7.  Burden and viral aetiology of influenza-like illness and acute respiratory infection in intensive care units.

Authors:  Fabio Tramuto; Carmelo Massimo Maida; Giuseppe Napoli; Caterina Mammina; Alessandra Casuccio; Cinzia Cala'; Emanuele Amodio; Francesco Vitale
Journal:  Microbes Infect       Date:  2015-12-17       Impact factor: 2.700

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.